
### [MONDO:0000105](http://purl.obolibrary.org/obo/MONDO_0000105)
**Label:** anemia, nonspherocytic hemolytic

**Subclasses:** [MONDO:0010480](http://purl.obolibrary.org/obo/MONDO_0010480) (anemia, nonspherocytic hemolytic, due to G6Pd deficiency), [MONDO:0008790](http://purl.obolibrary.org/obo/MONDO_0008790) (anemia, nonspherocytic hemolytic, possibly due to defect 1N porphyrin metabolism), [MONDO:0018750](http://purl.obolibrary.org/obo/MONDO_0018750) (class i glucose-6-phosphate dehydrogenase deficiency), [MONDO:0008789](http://purl.obolibrary.org/obo/MONDO_0008789) (anemia, nonspherocytic hemolytic, associated with abnormality of red cell membrane), 

**Mapped go classes:** [GO:0040014](http://purl.obolibrary.org/obo/GO_0040014) (regulation of multicellular organism growth), [GO:0009051](http://purl.obolibrary.org/obo/GO_0009051) (pentose-phosphate shunt, oxidative branch), [GO:0061052](http://purl.obolibrary.org/obo/GO_0061052) (negative regulation of cell growth involved in cardiac muscle cell development), [GO:0006740](http://purl.obolibrary.org/obo/GO_0006740) (NADPH regeneration), [GO:0043523](http://purl.obolibrary.org/obo/GO_0043523) (regulation of neuron apoptotic process), [GO:0006006](http://purl.obolibrary.org/obo/GO_0006006) (glucose metabolic process), [GO:0006741](http://purl.obolibrary.org/obo/GO_0006741) (NADP biosynthetic process), [GO:1904879](http://purl.obolibrary.org/obo/GO_1904879) (positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel), [GO:0009898](http://purl.obolibrary.org/obo/GO_0009898) (cytoplasmic side of plasma membrane), [GO:0043249](http://purl.obolibrary.org/obo/GO_0043249) (erythrocyte maturation), [GO:0004345](http://purl.obolibrary.org/obo/GO_0004345) (glucose-6-phosphate dehydrogenase activity), [GO:0045471](http://purl.obolibrary.org/obo/GO_0045471) (response to ethanol), [GO:0006979](http://purl.obolibrary.org/obo/GO_0006979) (response to oxidative stress), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0006739](http://purl.obolibrary.org/obo/GO_0006739) (NADP metabolic process), [GO:0019322](http://purl.obolibrary.org/obo/GO_0019322) (pentose biosynthetic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0010734](http://purl.obolibrary.org/obo/GO_0010734) (negative regulation of protein glutathionylation), [GO:0030246](http://purl.obolibrary.org/obo/GO_0030246) (carbohydrate binding), [GO:2000378](http://purl.obolibrary.org/obo/GO_2000378) (negative regulation of reactive oxygen species metabolic process), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0006098](http://purl.obolibrary.org/obo/GO_0006098) (pentose-phosphate shunt), [GO:0006695](http://purl.obolibrary.org/obo/GO_0006695) (cholesterol biosynthetic process), [GO:0048821](http://purl.obolibrary.org/obo/GO_0048821) (erythrocyte development), [GO:0042542](http://purl.obolibrary.org/obo/GO_0042542) (response to hydrogen peroxide), [GO:0002033](http://purl.obolibrary.org/obo/GO_0002033) (angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure), [GO:0005536](http://purl.obolibrary.org/obo/GO_0005536) (glucose binding), [GO:0005975](http://purl.obolibrary.org/obo/GO_0005975) (carbohydrate metabolic process), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0050661](http://purl.obolibrary.org/obo/GO_0050661) (NADP binding), [GO:0051156](http://purl.obolibrary.org/obo/GO_0051156) (glucose 6-phosphate metabolic process), [GO:0032615](http://purl.obolibrary.org/obo/GO_0032615) (interleukin-12 production), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0001998](http://purl.obolibrary.org/obo/GO_0001998) (angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure), [GO:0006749](http://purl.obolibrary.org/obo/GO_0006749) (glutathione metabolic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0034599](http://purl.obolibrary.org/obo/GO_0034599) (cellular response to oxidative stress), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0001816](http://purl.obolibrary.org/obo/GO_0001816) (cytokine production), [GO:0046390](http://purl.obolibrary.org/obo/GO_0046390) (ribose phosphate biosynthetic process), [GO:0032613](http://purl.obolibrary.org/obo/GO_0032613) (interleukin-10 production), 

**Class expressions from DL-Learner:**

- [GO:0032615](http://purl.obolibrary.org/obo/GO_0032615) (interleukin-12 production) 53.57%
- [GO:0032613](http://purl.obolibrary.org/obo/GO_0032613) (interleukin-10 production) 53.57%
- [GO:0002033](http://purl.obolibrary.org/obo/GO_0002033) (angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure) 53.57%
- [GO:0001998](http://purl.obolibrary.org/obo/GO_0001998) (angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure) 53.57%
- [GO:0045777](http://purl.obolibrary.org/obo/GO_0045777) (positive regulation of blood pressure) and [GO:0097756](http://purl.obolibrary.org/obo/GO_0097756) (negative regulation of blood vessel diameter) 53.57%
- [GO:0045777](http://purl.obolibrary.org/obo/GO_0045777) (positive regulation of blood pressure) and [GO:0097746](http://purl.obolibrary.org/obo/GO_0097746) (regulation of blood vessel diameter) 53.57%
- [GO:0042310](http://purl.obolibrary.org/obo/GO_0042310) (vasoconstriction) and [GO:0045777](http://purl.obolibrary.org/obo/GO_0045777) (positive regulation of blood pressure) 53.57%
- [GO:0008217](http://purl.obolibrary.org/obo/GO_0008217) (regulation of blood pressure) and [GO:0097756](http://purl.obolibrary.org/obo/GO_0097756) (negative regulation of blood vessel diameter) 53.57%
- [GO:0008217](http://purl.obolibrary.org/obo/GO_0008217) (regulation of blood pressure) and [GO:0042310](http://purl.obolibrary.org/obo/GO_0042310) (vasoconstriction) 53.57%
- [GO:0003084](http://purl.obolibrary.org/obo/GO_0003084) (positive regulation of systemic arterial blood pressure) and [GO:0097756](http://purl.obolibrary.org/obo/GO_0097756) (negative regulation of blood vessel diameter) 53.57%
- [GO:0003084](http://purl.obolibrary.org/obo/GO_0003084) (positive regulation of systemic arterial blood pressure) and [GO:0097746](http://purl.obolibrary.org/obo/GO_0097746) (regulation of blood vessel diameter) 53.57%
- [GO:0003084](http://purl.obolibrary.org/obo/GO_0003084) (positive regulation of systemic arterial blood pressure) and [GO:0042310](http://purl.obolibrary.org/obo/GO_0042310) (vasoconstriction) 53.57%
- Thing 52.39%
- [GO:0097756](http://purl.obolibrary.org/obo/GO_0097756) (negative regulation of blood vessel diameter) 38.93%
- [GO:0042310](http://purl.obolibrary.org/obo/GO_0042310) (vasoconstriction) 38.93%


